Increased Low Density Lipoprotein Particle Numbers in High Versus Low SLE Activity, A Potential Mechanism for Enhanced Cardiovascular Risk

被引：0
|
作者：
Durcan, L. [1 ]
Winegar, D. A. [2 ]
Connelly, M. A. [2 ]
Otvos, J. D. [2 ]
Magder, L. S. [3 ]
Petri, M. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Labcorp, Raleigh, NC USA
[3] Univ Maryland, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5.06
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [21] Lipoprotein(a) cardiovascular disease risk not captured by low density lipoprotein cholesterol and apolipoprotein B
    Thomas, P.
    Vedel-Krogh, S.
    Kamstrup, P. R.
    Nordestgaard, B. G.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [22] Apolipoprotein B, Low-Density Lipoprotein Particle Number, Non-High-Denisity Lipoprotein Cholesterol, Low-Density Lipoprotein Cholesterol, and Total Cholesterol for Atherosclerotic Cardiovascular Disease Risk Prediction in Young Adults
    Wilkins, John T.
    Ning, Hongyan
    Sawicki, Konrad
    Sawicki, Konrad T.
    Sniderman, Allan D.
    Otvos, James D.
    Rana, Jamal S.
    Murthy, Venkatesh
    Murthy, Venkatesh L.
    Shah, Ravi V.
    Allen, Norrina B.
    Lloyd-Jones, Donald
    CIRCULATION, 2023, 147
  • [23] Low high-density lipoprotein cholesterol and cardiovascular disease: Risk reduction with statin therapy
    Rosenson, RS
    AMERICAN HEART JOURNAL, 2006, 151 (03) : 556 - 563
  • [24] Interventions to Lower Low-Density Lipoprotein Cholesterol and Cardiovascular Risk
    Zafar, Kamran
    Inayat, Maimoona
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 439 - 440
  • [25] Low-Density Lipoprotein Levels and Risk of Major Cardiovascular Events
    Rott, David
    JAMA INTERNAL MEDICINE, 2016, 176 (12) : 1876 - 1876
  • [26] Increased oxidized low density lipoprotein associated with high ceruloplasmin activity in patients with active acromegaly
    Boero, L.
    Cuniberti, L.
    Magnani, N.
    Manavela, M.
    Yapur, V.
    Bustos, M.
    Gomez Rosso, L.
    Merono, T.
    Marziali, L.
    Viale, L.
    Evelson, P.
    Negri, G.
    Brites, F.
    CLINICAL ENDOCRINOLOGY, 2010, 72 (05) : 654 - 660
  • [27] Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects
    Bakillah, Ahmed
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (01) : 60 - 69
  • [28] Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein, Apolipoprotein, or Low-Density Lipoprotein Particle What Should Clinicians Measure?
    Davidson, Michael H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (25) : 2616 - 2617
  • [29] Could high-density lipoprotein cholesterol predict increased cardiovascular risk?
    Chang, Tae Ik
    Streja, Elani
    Moradi, Hamid
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (02) : 140 - 147
  • [30] Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol
    Sniderman, Allan D.
    Islam, Shofiqul
    McQueen, Matthew
    Pencina, Michael
    Furberg, Curt D.
    Thanassoulis, George
    Yusuf, Salim
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (10):
12345